Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer

Tetraspanin CD151 Regulates Growth of Mammary Epithelial Cells in Three-Dimensional Extracellular Matrix: Implication for Mammary Ductal Carcinoma In situ

(2010) Vera Novitskaya et al.   CANCER RESEARCH

Tetraspanin CD151 Regulates Transforming Growth Factor   Signaling: Implication in Tumor Metastasis

(2010) R. Sadej et al.   CANCER RESEARCH

Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets

(2010) Christopher S. Stipp   EXPERT REVIEWS IN MOLECULAR MEDICINE

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

CD151 Regulates Tumorigenesis by Modulating the Communication between Tumor Cells and Endothelium

(2009) R. Sadej et al.   MOLECULAR CANCER RESEARCH

The Inhibition of Tumor Cell Intravasation and Subsequent Metastasis via Regulation of In Vivo Tumor Cell Motility by the Tetraspanin CD151

(2008) Andries Zijlstra et al.   CANCER CELL

Regulation of CD151 by Hypoxia Controls Cell Adhesion and Metastasis in Colorectal Cancer

(2008) C.-W. Chien et al.   CLINICAL CANCER RESEARCH

Serous carcinoma of the uterus-determination of HER-2/neu status using immunohistochemistry, chromogenicin situhybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation

(2008) P. SINGH et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

(2008)   LANCET

Targeting of tetraspanin proteins — potential benefits and strategies

(2008) Martin E. Hemler   NATURE REVIEWS DRUG DISCOVERY